- Report
- December 2018
- 48 Pages
Global
From €3261EUR$3,495USD£2,755GBP
- Report
- August 2022
United States
From €1810EUR$1,940USD£1,529GBP
- Report
- August 2022
Global
From €924EUR$990USD£780GBP
- Report
- August 2021
Global
From €3723EUR$3,990USD£3,145GBP
- Report
- August 2021
Europe
From €3191EUR$3,420USD£2,695GBP
- Report
- February 2021
Global
From €2762EUR$2,960USD£2,333GBP
- Report
- January 2020
- 130 Pages
Global
From €10259EUR$10,995USD£8,666GBP
- Report
- September 2020
- 65 Pages
Global
€1230EUR$1,318USD£1,039GBP
- Drug Pipelines
- November 2020
- 355 Pages
Global
From €1866EUR$2,000USD£1,576GBP
- Report
- July 2023
- 218 Pages
Global
From €4199EUR$4,500USD£3,547GBP
- Drug Pipelines
- July 2018
- 503 Pages
Global
From €20527EUR$22,000USD£17,339GBP
- Report
- January 2024
- 85 Pages
Global
From €3500EUR$4,018USD£3,060GBP
- Report
- October 2022
- 182 Pages
Global
From €1866EUR$2,000USD£1,576GBP
- Report
- April 2023
- 160 Pages
Global
From €5597EUR$5,999USD£4,728GBP
- Report
- May 2023
- 160 Pages
Global
From €5597EUR$5,999USD£4,728GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
Psoriatic Arthritis Drug is a type of drug used to treat psoriatic arthritis, a type of immune disorder. It is a chronic, inflammatory condition that affects the joints and skin. Psoriatic Arthritis Drug works by targeting the underlying cause of the disease, which is an overactive immune system. It helps to reduce inflammation and pain, and can also slow down the progression of the disease. Commonly used Psoriatic Arthritis Drugs include biologics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs).
The Psoriatic Arthritis Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of psoriatic arthritis, as well as the development of new and more effective treatments. The market is expected to continue to grow in the coming years, as more treatments become available and the demand for them increases.
Some of the major companies in the Psoriatic Arthritis Drug market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, Pfizer, and Roche. Show Less Read more